Do I need an in-person exam for Strattera in Florida?

In today’s fast-paced world, telehealth has revolutionized how we access healthcare, especially for conditions like ADHD. If you’re considering non-stimulant medications such as Strattera (atomoxetine) for ADHD treatment, you may wonder: ‘Can I get these prescribed online?’ The answer is generally yes – but there are important nuances to understand about telehealth prescribing in 2025.

This comprehensive guide breaks down everything you need to know about getting non-stimulant ADHD medications through telehealth services, including current regulations, state-specific rules, and what to expect during the process.

Non-Stimulant ADHD Medications: The Telehealth Advantage

Unlike stimulant medications (Adderall, Ritalin, etc.), non-stimulants such as Strattera offer several advantages when it comes to telehealth prescribing:

• No DEA controlled substance restrictions: Strattera is not a controlled substance, meaning it isn’t subject to the strict federal regulations that govern stimulants
• Fewer prescribing limitations: Can often be prescribed with refills and in 90-day supplies
• No risk of dependency: Non-habit forming, which means less concern about misuse
• Consistent coverage: Less affected by changing telehealth regulations

‘Strattera contains atomoxetine, which is not a controlled substance. This means it has no federally recognized potential for abuse or addiction, unlike stimulant ADHD medications.’ – Medical News Today, 2025

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Current Telehealth Regulations for Non-Stimulant ADHD Medications

Federal Rules (2025 Status)

The good news for patients seeking non-stimulant ADHD treatments is that federal law imposes no special restrictions on prescribing medications like Strattera via telehealth. Since Strattera is not classified as a controlled substance, it falls outside the scope of the Ryan Haight Act’s in-person examination requirements.

For context, while stimulant medications are currently allowed via telehealth under the DEA’s ‘Third Extension’ of COVID-era flexibilities (set to expire December 31, 2025), non-stimulants like Strattera have always been legally prescribable through telehealth platforms, regardless of pandemic exceptions.

State-by-State Telehealth Rules for Non-Stimulants

While federal law allows telehealth prescribing of non-stimulants, state regulations can vary significantly. Here’s how key states handle non-stimulant ADHD telehealth prescribing:

California

• Telehealth permitted: Yes, fully allowed for non-stimulants
• In-person requirement: None for non-stimulants
• Provider types: Both physicians and NPs can prescribe independently

New York

• Telehealth permitted: Yes, with no restrictions for non-stimulants
• In-person requirement: None for Strattera (though NY reinstated in-person requirements for controlled substances in 2025)
• Provider types: Physicians, NPs (after 3,600 practice hours), and PAs can prescribe non-stimulants

Florida

• Telehealth permitted: Yes, including for ADHD treatment
• In-person requirement: None for non-controlled medications
• Provider types: Physicians, NPs, and PAs (under collaboration) can prescribe

Texas

• Telehealth permitted: Yes, especially for mental health conditions
• In-person requirement: None for non-stimulants
• Provider types: Physicians and supervising NPs/PAs can prescribe non-stimulants

Alabama

• Telehealth permitted: Yes, but with some limitations
• In-person requirement: For ongoing telehealth treatment (beyond 4 visits), an in-person visit is generally required within 12 months, though mental health services are exempt
• Provider types: Physicians and supervised NPs/PAs can prescribe non-stimulants

Georgia

• Telehealth permitted: Yes, with no special restrictions for non-stimulants
• In-person requirement: None for non-controlled substances
• Provider types: Physicians and supervised NPs/PAs can prescribe non-stimulants (though NPs/PAs cannot prescribe Schedule II stimulants in Georgia)

‘Most states have embraced telehealth for mental health conditions, including ADHD, recognizing that consistent care can be delivered effectively through virtual platforms, particularly for medication management.’ – National Law Review, 2025

Who Can Prescribe Non-Stimulant ADHD Medications via Telehealth?

The authority to prescribe medications via telehealth varies by provider type and state:

Physicians (MD/DO)

In all 50 states, licensed physicians can prescribe non-stimulant ADHD medications like Strattera through telehealth platforms, provided they:

• Are licensed in the patient’s state
• Conduct a proper clinical evaluation (via video)
• Follow standard of care guidelines
• Document the visit appropriately

Nurse Practitioners (NPs)

NPs can prescribe non-stimulant ADHD medications in all states, though their level of independence varies:

• Full independent authority: States like New York, California, and New Hampshire allow NPs to prescribe without physician oversight (usually after completing certain experience requirements)
• Collaborative practice: States including Florida, Texas, and Georgia require NPs to have a physician agreement or supervision
• Restricted: Some states limit NP prescribing of controlled substances, but these limitations generally don’t apply to non-stimulants like Strattera

Physician Assistants (PAs)

PAs can generally prescribe non-stimulant ADHD medications in all states under physician supervision or collaboration.

The Telehealth ADHD Assessment Process

When seeking non-stimulant ADHD treatment through telehealth, here’s what to expect:

Initial Evaluation

A thorough initial assessment typically includes:

• Comprehensive intake questionnaires: Detailed history of symptoms, medical conditions, and previous treatments
• Video consultation: A face-to-face video appointment with a licensed provider
• ADHD screening tools: Standardized assessments based on DSM-5 criteria
• Medical history review: Discussion of any contraindications or concerns
• Treatment planning: Collaborative decision-making about medication options

At Klarity Health, these evaluations are conducted by licensed providers who specialize in ADHD treatment, ensuring you receive expert care tailored to your specific needs.

Follow-Up Care

Unlike stimulant medications that work immediately, Strattera and other non-stimulants may take 4-6 weeks to reach full effectiveness. Your telehealth follow-up plan should include:

• Regular check-ins to monitor progress
• Dose adjustments as needed
• Side effect management
• Long-term treatment planning

What Makes You a Good Candidate for Online Non-Stimulant ADHD Treatment?

Telehealth non-stimulant treatment may be ideal if you:

• Have a diagnosis or symptoms of ADHD
• Prefer a non-stimulant option or have had side effects from stimulants
• Don’t have severe comorbid conditions requiring in-person care
• Want convenient, consistent access to treatment
• Have reliable internet access for video appointments

You might not be a good candidate if you:

• Have uncontrolled psychiatric conditions needing in-person care
• Have medical contraindications to non-stimulant medications
• Require physical examinations that can’t be conducted virtually
• Prefer stimulant medications and live in a state with in-person requirements

Common Misconceptions About Telehealth ADHD Treatment

Myth: ‘Non-stimulants aren’t effective for ADHD’

Reality: While stimulants are often first-line treatments, non-stimulants like Strattera can be very effective, particularly for patients who:

• Experience unwanted side effects from stimulants
• Have anxiety that worsens with stimulants
• Need 24-hour symptom control (Strattera works continuously, unlike stimulants that wear off)
• Have concerns about stimulant misuse or dependency

Myth: ‘Online ADHD prescriptions are automatic’

Reality: Legitimate telehealth providers conduct comprehensive evaluations before prescribing any medication. A proper assessment includes detailed history-taking, symptom analysis, and discussion of treatment options—just like an in-person visit.

Myth: ‘Telehealth prescriptions won’t be filled by local pharmacies’

Reality: Pharmacies routinely fill prescriptions from licensed telehealth providers. Since Strattera isn’t a controlled substance, these prescriptions typically face even fewer obstacles than stimulants.

Tips

Source:

• https://www.fiercehealthcare.com/regulatory/dea-finalizes-one-year-extension-controlled-substance-prescribing-telehealth-punts-final#:~:text=The%20Drug%20Enforcement%20Administration%20,Federal%20Register%20on%20Friday%20night
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=visit,examination%20through%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.fiercehealthcare.com/regulatory/dea-finalizes-one-year-extension-controlled-substance-prescribing-telehealth-punts-final#:~:text=The%20%E2%80%9CThird%20Temporary%20Extension%20of,14
• https://www.medicalnewstoday.com/articles/drugs-is-strattera-a-controlled-substance#:~:text=Strattera%20,such%20as%20mental%20health%20issues
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.rxagent.co/blog/telehealth-compliance-trap#:~:text=The%20,False%20Hope
• https://www.techtarget.com/virtualhealthcare/news/366616019/Telehealth-prescribing-flexibility-extended-through-2025#:~:text=Image%20filo%2FDigitalVision%20Vectors%20via%20G,The
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Extend%20natlawreview,before%20issuing%20a%20dangerous%20drug
• https://www.rxagent.co/blog/telehealth-compliance-trap#:~:text=,specifically%20for%20chronic%20pain%20treatment